Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 26, 2025MedScienOpen Access

Natural Killer Cells Therapy: From in Vitro Amplification to Engineering Modification

View Full Paper
Ask AI
Bookmark
Share

Authors

JCJun Chen

Discussion

Loading...

Member takes

Overview

Review highlights NK cell-based immunotherapy advancements, showing promise despite persistent challenges.

Key Points

  • Natural killer (NK) cell therapy shows a 50%-70% response rate in treating B-cell lymphoma, revealing its potential in immunotherapy.
  • Research indicates that cytokine and feeder layer systems can expand NK cells over 500-fold, enhancing their therapeutic viability.
  • Genetic engineering strategies, including CRISPR, have been proven to enhance NK cells' effectiveness against solid tumors.
  • NK cell therapy's near-zero graft-versus-host disease risk underscores its safety profile, but requires overcoming significant challenges for broader use.

Cite This Study

Jun Chen (2025) studied this question.

synapsesocial.com/papers/68af7c8d7567bf4f94ff3f3fhttps://doi.org/10.61173/j13x9317
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Recent advances in tumor immunotherapy based on NK cells2025
  2. 2Engineered NK Cells: A Breakthrough Strategy to Overcome Cancer Immunosuppression2025
  3. 3Natural Killer Cell‐Mediated Antitumor Immunity: Molecular Mechanisms and Clinical Applications2025 · 5 citations
  4. 4Natural killer cell-based immunotherapies for colorectal cancer: Current strategies, challenges, and future perspectives2025
  5. 5Clinical trials of nanoparticle-enhanced CAR-T and NK cell therapies in oncology: overcoming translational and clinical challenges - a mini review2025 · 16 citations